Preclinical molecular imaging enables researchers to identify the pathways of disease and the action of novel therapies in living animals. Making translational research “from mouse to man” possible. With the largest installation base in the industry and a broad spectrum of technologies, we provide the most complete array of preclinical imaging tools. Our preclinical PET, SPECT, CT, and hybrid imaging systems and leading edge applications go further to facilitate basic research, as well as the drug development process empowering researchers to identify specific biological processes, monitor the efficacy of compounds, and measure the effects of disease progression over time.